logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Stephen J. Freedland

cedars-sinai medical center

98H-index
1.6KPaper Count
4.3WCitation Count
Published Papers 802
Publication Date
logo
Reply to Francesco Barletta, Chiara Mercinelli, Francesco Montorsi, et al. re: Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.019
errEuropean Urology
IF25.2
err2026-07-11
err0
PREAI
errNeal D. Shore; Stephen J. Freedland
errShare
errSave
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice
errFuture Oncology
IF2.6
err2026-07-09
err0
errOAAI
errStephen J. Freedland; Neal D. Shore
errShare
errSave
Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice
errFuture Oncology
IF2.6
err2026-06-23
err0
PREAI
errStephen J. Freedland; Ugo De Giorgi
errShare
errSave
Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer
errAdvances in Therapy
IF4
err2026-06-01
err0
errOAAI
errStephen J. Freedland; Amanda Ribbands; David Russell; Jake Butcher; Tom Brown; Christopher S. Bland; Maëlys Touya; Jasmina I. Ivanova
errShare
errSave
Marital status and post-radical prostatectomy outcomes: results from the SEARCH database
errSupportive Care in Cancer
IF3
err2026-05-19
err0
errOAAI
errAlanna Burwell; Jaruda Ithisuphalap; Jessica L. Janes; Vanessa M. Helms; Christopher L. Amling; William J. Aronson; Matthew R. Cooperberg; Christopher J. Kane; Zachary Klaassen; Martha K. Terris; Lourdes Guerrios Rivera; Stephen J. Freedland; Alix G. Sleight
errShare
errSave
A WEIGHTED SCALE TO IDENTIFY EMBARK-LIKE PATIENTS AT HIGH-RISK FOR PROGRESSION AND MORTALITY AFTER BIOCHEMICAL RECURRENCE (BCR) WHO MAY BENEFIT FROM EARLY INTENSIFIED ADT
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errFriedrich, Nadine A.; Luu, Michael; Janes, Jessica L.; Kokorowski, Paul; Klaassen, Zachary; Mogollon, Maria P.; Terris, Martha; Kane, Christopher J.; Amling, Christopher; Cooperberg, Matthew R.; Rivera, Lourdes Guerrios; Aronson, William; Freedland, Stephen J.; Daskivich, Timothy J.
errShare
errSave
ALCOHOL CONSUMPTION AND HISTOLOGIC PROSTATIC INFLAMMATION: A POST-HOC ANALYSIS OF THE REDUCE TRIAL
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errHernandez-Tirado, Alexander; Friedrich, Nadine A.; Mogollon, Maria P.; Moreira, Daniel M.; Freedland, Stephen J.; Nik-Ahd, Farnoosh
errShare
errSave
DURATION OF TREATMENT SUSPENSION AMONG ALL RANDOMIZED PATIENTS IN EMBARK
errJournal of Urology
IF6.8
err2026-05-01
err0
PREAI
errShore, Neal D.; Sieber, Paul R.; De Giorgi, Ugo; Danila, Daniel C.; Dunshee, Curtis J.; Lallas, Costas D.; Pliskin, Marc J.; Morgans, Alicia K.; Tang, Yiyun; Rosales, Matt; Wang, Fong; Kennedy, Dana; Freedland, Stephen J.
errShare
errSave
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
errJournal of Urology
IF6.8
err2026-05-01
err6
PREAI
errShore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J.
errShare
errSave
Lifestyle matters: physical activity and prostate cancer progression
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-03-23
err0
PREAI
errAlanna Burwell; Maria P. Mogollon; Gillian Gresham; Stephen J. Freedland
errShare
errSave
Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer?
errClinical Genitourinary Cancer
IF2.7
err2026-03-01
err0
PREAI
errMorgans, Alicia K.; Touya, Maelys; El-Chaar, Nader; Elsouda, Dina; Mucha, Lisa; Ramaswamy, Krishnan; Adejumo, Kelechi L.; Schuler, Tammy; Sharpe, Jason; Feinberg, Bruce; Asgarisabet, Parisa; Pathak, Prathamesh; Freedland, Stephen J.
errShare
errSave
Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort
errProstate Cancer and Prostatic Diseases
IF5.8
err2026-01-07
err0
errOAAI
errAlexandra Mack; Trung Duong Tran; Emelie Berglund; Gerald L. Andriole; Christopher Alley; Anthony E. Sisk; Iveth Estrada-Reyes; Kara Bissell; Haleigh Bellerose; Aubrey Jarman; Anna Hoffmeyer; Michael Burns; Sergio Sanders; Eric Vail; Andy Pao; Raja Khurram; Amal Ahmed; Stephen J. Freedland
errShare
errSave
Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?
errClinical Genitourinary Cancer
IF2.7
err2026-01-01
err0
PREAI
errFriedrich, Nadine A.; Luu, Michael; Gale, Rebecca; Chaplin, Antwon; Polineni, Reva; Shiang, Alex; Shin, Dong; Freedland, Stephen J.; Spiegel, Brennan; Ballas, Leslie K.; Kokorowski, Paul; Daskivich, Timothy J.
errShare
errSave
Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based Studies
errCANCER MEDICINE
IF3.1
err2025-12-21
err0
errOAAI
errStock, Shannon R.; Parrish, Joshua A.; Burns, Michael T.; Janes, Jessica L.; Waller, Justin; De Hoedt, Amanda M.; Ghate, Sameer; Kim, Jeri; Shui, Irene M.; Freedland, Stephen J.
errShare
errSave
Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges
errEuropean Urology Focus
IF5.6
err2025-12-18
err0
errOAAI
errNeal D. Shore; Stephen J. Freedland; Lisa G. Horvath; Joe M. O’Sullivan; Ugo De Giorgi; Edward C. Ray; Ashley E. Ross; Yiyun Tang; David Russell; Kenneth K. Iwata; Matt Rosales; Arijit Ganguli; Bertrand Tombal
errShare
errSave
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
errProstate Cancer and Prostatic Diseases
IF5.8
err2025-12-09
err0
errOAAI
errUdit Singhal; Ralph Jiang; James A. Proudfoot; Elizabeth Chase; Krithika Suresh; Elai Davicioni; Tudor Borza; Michael J. Zelefsky; Brian J. Davis; Brad J. Stish; R. Jeffrey Karnes; Stephen J. Freedland; Martha K. Terris; William J. Aronson; Matthew R. Cooperberg; Fabio Y. Moraes; Alejandro Berlin; Curtiland Deville; Nicholas G. Zaorsky; Soumyajit Roy; Angela Y. Jia; Jonathan E. Shoag; William C. Jackson; Daniel E. Spratt; Matthew Schipper; Todd M. Morgan; Robert T. Dess
errShare
errSave
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age
errEuropean Journal of Cancer
IF7.1
err2025-11-15
err0
PREAI
errNeal D. Shore; Ugo De Giorgi; Matko Kalac; Yiyun Tang; Ruslan Croitoru; Matt Rosales; Melissa J. Huynh; Igle J. de Jong; Christopher P. Evans; Flavio M. Carcano; Stephen J. Freedland
errShare
errSave
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health Administration
errAdvances in Therapy
IF4
err2025-11-01
err0
errOAAI
errStephen J. Freedland; Krishnan Ramaswamy; Abhishek Kavati; Wei Gao; Juan F. Razo; Michele Cole; Benjamin Li; Hongbo Yang; Tracy Guo; Grace Chen; Rana R. McKay
errShare
errSave
Adherence and Persistence on Relugolix for the Treatment of Prostate Cancer in the United States Medicare Fee-for-Service Population
errUROLOGY PRACTICE
IF1.7
err2025-11-01
err0
PREAI
errMcKay, Rana R.; Hong, Agnes; Razo, Juan F.; Flanders, Scott C.; Ferro, Christine; Shapoval, Mila; Li, Benjamin; Freedland, Stephen J.
errShare
errSave
The potential of (177Lu)-PSMA-617 in the first-line combination therapy with enzalutamide for metastatic castration-resistant prostate cancer: clinical insights from the ENZA-p trial
errCHINESE CLINICAL ONCOLOGY
IF2.5
err2025-10-31
err0
PREAI
errZheng, Renning; Freedland, Stephen J.; Nguyen, Anthony T.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
G
Graham G. Giles
H-index: 164 · Papers: 2.4K
P
Peter R. Carroll
H-index: 149 · Papers: 1.4K
P
Peter T. Scardino
H-index: 149 · Papers: 1.2K
N
Nancy J. Cox
H-index: 147 · Papers: 1.1K
View more